Operator Roundtable Discussion
Marijuana Rescheduling and Your Testing Program
A complimentary half-day briefing for operator clients.
Houston, TX – Thursday, November 5, 2026
Hyatt Regency Houston Downtown
In April 2026, FDA-approved marijuana drug products and state-licensed medical marijuana were placed in Schedule III. A broader rescheduling proceeding is still underway. DOT’s position, so far, has not changed; however, that possibility remains.
Join NCMS and a room of your peers in downtown Houston to work through what’s settled, what isn’t, and what it means for your DOT and Non-DOT programs.
What we'll cover
- Where rescheduling actually stands
A brief walkthrough of the April 2026 order, the pending proceedings, and DOT’s current status. Plus, we’ll discuss the potential impacts. - A first look at NCMS Connect
We’ll show you glimpses of our new contractor monitoring web platform – NCMS Connect. We’ll discuss the features and roadmap. We’ll have time to get your input too. - Lunch with ISNetworld
ISN representatives will join us over lunch and take questions directly from you.
Agenda
9:00 – 10:15am – Marijuana Rescheduling: Where It Stands and What it Means for Your Program
10:15 – 10:30am – Break
10:30 – 11:30am – NCMS Connect: Progress Review and Your Priorities
11:30am – 12:30pm – Lunch with ISNetworld: Open Q&A
Details
Date: Thursday, November 5, 2026
Time: 9:00am – 12:30pm
Location: Hyatt Regency Houston Downtown, 1200 Louisiana St, Houston, TX 77002
Cost: Complimentary, including lunch
